Walleye Trading’s Checkpoint Therapeutics CKPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,000
Closed -$60.6K 4278
2025
Q1
$60.6K Buy
+15,000
New +$50K ﹤0.01% 3562

Walleye Trading's CKPT Position: Q2 2025 in Review

Walleye Trading sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 15,000 shares — an estimated $60.6K sold.

Walleye Trading first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $60.6K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

  • Walleye Trading reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Walleye Trading sold 15,000 Checkpoint Therapeutics shares in Q2 2025, an estimated $60.6K.
  • Walleye Trading first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
  • Walleye Trading's Checkpoint Therapeutics position peaked at $60.6K in Q1 2025.
  • 0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Walleye Trading's 13F filing for Q2 2025, filed 13 Aug 2025.